Jorge Gutierrez
Interventional Cardiology · Durham, NCNPI 1669630968
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,305 of the $31,997 with a category attached, or 69.7%. 16 manufacturers reported payments, led by Recor Medical Inc at 45.3% of the total. 2025 is the largest year on record at $18,031, more than ten times the $313 reported in 2019.
Across 90 payments — averaging $355.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Recor Medical Inc$15K
- Boston Scientific$7K
- Biotronik Inc.$4K
- Janssen Global Services, LLC$3K
- Johnson & Johnson$2K
- Medicure Pharma Inc.$700
- plus $693 from 10 others
Across 22 payments — averaging $9551.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$144K
- Recor Medical Inc$66K
What the payments were for
- Consulting fees$22,30570%
- Speaking & faculty fees$3,25010%
- Travel & lodging$1,6095%
- Food & beverage$4,83315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Recor Medical Inc | 25 | $14,510 |
| Boston Scientific | 39 | $7,239 |
| Biotronik Inc. | 2 | $3,800 |
| Janssen Global Services, LLC | 1 | $3,030 |
| Johnson & Johnson | 1 | $2,025 |
| Medicure Pharma Inc. | 3 | $700 |
| Bard Peripheral Vascular, Inc. | 4 | $207 |
| Cardiovascular Systems Inc. | 1 | $175 |
| Boehringer Ingelheim | 5 | $88 |
| Abbott | 2 | $57 |
| Novartis | 1 | $49 |
| Medtronic | 2 | $48 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Terumo Medical Corporation | 1 | $18 |
| Pfizer | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Paradise Ultrasound Renal Denervation System$13,897
- PK Papyrus$3,400
- XARELTO$2,025
- GENERAL - THERAPIES$1,335
- AVVIGO Guidance System$1,000
- Aggrastat (tirofiban HCl)$400
- Orsiro Mission$400
- Acute cardiovascular care$300
- PARADISE RENAL DENERVATION SYSTEM$294
- Coronary Orbital Atherectomy System$175
- OPTICROSS$134
- GENERAL - STENTS$118
How this compares
$31,997 in reported general payments places this provider in the 80th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $9,785 |
| Metoprolol Succinate | 14 | $147 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $9,78511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 180 interventional cardiology providers in North Carolina.
Other interventional cardiology in Durham
- Dennis NarcisseDurham$100K
- Rajesh SwaminathanDurham$82K
- William JonesDurham$36K
- Andres Pineda MaldonadoDurham$17K
- George AdamsGarner$4.1M
- Paul MahoneyGreenville$1.7M
- Ravish SacharRaleigh$1.6M
- Patrick SimpsonPinehurst$579K
- Ronald UszenskiMooresville$495K
- Oluseun AlliCharlotte$485K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.